Rectal Cancer

Take this Activity

  Rectal Cancer

Credits: 1.25   Post-Assessment Questions:  5

Release Date: 5 Oct 2020
Expiration Date: 17 Dec 2021
Last Reviewed: 17 Dec 2020
Estimated Time To Finish: 75 Minutes

Need Help?  If you have a system or content concerns, please contact support@statpearls.com, or call (727) 289-9796.

Activity Description

Colon and rectal cancers together are the third most commonly diagnosed cancer in the United States and the second deadliest. Rectal cancer has distinct environmental associations and genetic risk factors different from colon cancer. The incidence of new cases and mortality of rectal cancer has been steadily declining for the past years, although noticed to rise in recent years on younger adults (less than 50 years). The transformation of the normal rectal epithelium to a dysplastic lesion and eventually an invasive carcinoma requires an accumulation of genetic mutations either somatic (acquired) and/or germline (inherited) over an approximately 10 to 15 years period. Tumor regression grade after pre-operative therapy and pathological staging are the most important prognostic indicators of rectal cancer. All newly diagnosed patients with rectal cancer should be universally screened for DNA mismatch repair/microsatellite status present in up to 13% of all sporadic rectal cancer cases. A careful history and physical examination, including a digital rectal exam, are paramount on clinical suspicion. An endoscopy examination with rigid sigmoidoscopy is required to measure the distance from the lesion to the anal verge (less than 15 cm) and for tissue biopsy for pathological confirmation of rectal cancer. This activity reviews the cause, pathophysiology, presentation, and diagnosis of rectal cancer and highlights the interprofessional team's role in its management.

Target Audience

This activity has been designed to meet the educational needs of physicians.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the etiology of rectal cancer.
  • Review the workup of rectal cancer.
  • Outline the treatment and management options available for rectal cancer.

Author(s) / Contributors Disclosure of Conflicts of Interest

Each author, editor, faculty and planning committee member have completed a disclosure form indicating that neither they nor their spouse/partner has a financial interest/arrangement or affiliation that could be perceived as a real or apparent conflict of interest related to the content of this activity.

COMMERCIAL SUPPORT: This activity has received NO commercial support.

Contributors

Hover over the contributor names to see details and disclosures of any financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity.

Authors: Alejandro Recio-Boiles, Sarang Kashyap, Andrea Tsoris
Editors: Hani Babiker
Editors-In-Chief: Joshua TuckPrashanth AnandMatthew Varacallo
Chief Medical Reviewer: Shiva Kumar Mukkamalla
Nurse Planner/Reviewer/Editor: Lisa Haddad
Nurse Planner/Reviewer/Editor: Bernadette Makar
Nurse Planner/Reviewer/Editor: Dorothy Caputo
Pharmacy Planner/Reviewer/Editor: Mark Pellegrini
Physician Planner/Reviewer/Editor: Scott Dulebohn

Continuing Education Accreditation Information


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Quillen College of Medicine, East Tennessee State University, and StatPearls, LLC. The Quillen College of Medicine, East Tennessee State University is accredited by the ACCME to provide continuing medical education for physicians.

Quillen College of Medicine, East Tennessee State University designates this activity for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

 

Cancellation Policy: Cancellations must be received in writing and a money-back guarantee is provided if not completely satisfied.

  • StatPearls and ETSU reserve the right to cancel any course due to unforeseen circumstances. StatPearls and ETSU will not be responsible for other expenses incurred by the participant in the unlikely event that the program is canceled.

Equal Opportunity

  • StatPearls and ETSU are Equal Opportunity / Affirmative Action / Equal Access Institutions. 

Medium or Media Used:

  • Computer Requirements:  Internet Access
  • E-mail Address

Instructions for Credit

  1. Register for the activity and create a StatPearls login.     
  2. Review the required accreditation information:  Target audience, learning objectives, and disclosure information.
  3. Complete the entire self-study activity.
  4. Complete the post-test assessments.
  5. Successfully pass the post-test with a minimum score of 100%.
  6. Complete the evaluation form.
  7. Obtain a certificate.

StatPearls and ETSU adhere to ACCME Standards regarding commercial support of continuing medical education. It is the policy of StatPearls and ETSU that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved, and also that authors and editors will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made prior to starting the activity.

The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

Media Usage Rights

The contributors and editors of StatPearls have attested that all associated media (images and video) have been legally cleared for use with this activity.  All copyrights are reserved.

    Average Rating: -.-

    5 Star
    4 Star
    3 Star
    2 Star
    1 Star

    Unlimited Physician MD/DO/PA CME

    Stay up to date on the latest medical knowledge with 6014 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 6500.5 hours of CME.


    6 Month Unlimited Physician MD/DO/PA CME

    $199

    Access to all the Physician MD/DO/PA CME activities in all specialties.
    1 Year Unlimited Physician MD/DO/PA CME

    $299

    Access to all the Physician MD/DO/PA CME activities in all specialties.